Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients With Stable Schizophrenia
Clinical and Translational Science - United Kingdom
doi 10.1111/cts.12545
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 10, 2018
Authors
Publisher
Wiley